Blood cancers, Cell type, High grade lymphoma, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 1
This study used magnetic resonance spectroscopy (MRS) to study chemical activity in Non Hodgkin lymphoma (NHL) and predict treatment outcomes.
It was for people with a type of NHL called diffuse large B-cell lymphoma (DLBCL) who were having for the first time.
Recruitment start: 22 February 2008
Recruitment end: 1 April 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor John Griffiths
Cancer Research UK
Department of Health (UK)
EPSRC Cancer Imaging centre
Experimental Cancer Medicine Centre (ECMC)
Medical Research Council
National Health System (UK)
National Institute of Health (US)
NIHR Oxford Biomedical Research Centre
Last reviewed: 11 September 2016
CRUK internal database number: 2851
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
